๐ŸงฌTidera Health

Tidera provides educational trial discovery tools and does not provide medical advice or determine eligibility. Always discuss options with your care team.

Drug Pipeline9 min read

GLP-1 and Obesity Drug Clinical Trials in 2025: Beyond Ozempic

By Tidera Health Editorial Teamยท

The GLP-1 revolution is far from over. New formulations, combinations, and indications are in trials. Here's what's coming in 2025 and beyond.

About this article: Educational and informational only. Does not constitute medical advice or eligibility guidance. Always discuss clinical trial options with your care team. Verify current trial status at ClinicalTrials.gov.

What You Need to Know

GLP-1 agonists have transformed obesity medicine. Here's what's next in clinical development โ€” including oral GLP-1s, GIP/GLP combinations, and trials for non-diabetic obesity.

Find recruiting trials for your condition

Search ClinicalTrials.gov in real time โ€” matched to your profile, explained in plain English. Free, no account required.

Start Free Search โ†’

How Tidera Health Can Help

Tidera Health searches ClinicalTrials.gov in real time and uses AI to explain which trials may be relevant to your condition, age, location, and treatment history. It's free, requires no account, and stores no health data.

Enter your condition and location to see currently recruiting trials matched to your profile โ€” with plain-English eligibility explanations and questions to ask the research coordinator.

Topics

GLP-1 trialobesity drug trialsemaglutide trialtirzepatide trialweight loss clinical trial

Find recruiting trials for your condition

Enter your condition, age, and location. We search ClinicalTrials.gov in real time and explain each trial in plain English. Free, no account required.